NutraNomics (NNRX) Provides Detailed Shareholder Update
10 Settembre 2018 - 10:42PM
InvestorsHub NewsWire
NutraNomics (NNRX) Provides Detailed
Shareholder Update
Salt Lake City, UT. -- September 10, 2018 --
Investorshub NewsWire -- NutraNomics, Inc. formerly DBA Health
Education Corp. (USOTC:NNRX) has a long and dedicated history as an
industry leader in the nutraceutical and overall wellness markets.
We are a significant contributor in these markets through internal
and third party partner scientific research, as well as innovation
in product development within the nutraceutical market. First and
foremost, we focus on clinically-proven formulas with applications
in nutritional supplements, personal care, and post treatment
therapy.
Over the last year and a half, the organization has restructured
its financial position and strategies. The revamp has brought a
marketing focus with innovation that is a state-of-the-art
combination of technology and analytics. NutraNomics is much more
diversified and market ready for the right customer with the right
products. This new identity rounded us out with investments in IT
architecture, customer relations, centralization in manufacturing
and control points that have tools built for expanding market share
and profits. In addition, with our diversified but laser focus
characterization, we have on-boarded physicians and formulators who
are experts in their fields which allows us to be a "one stop shop"
controlling all the endpoints of the process and always evolving.
This resurgence of who we are is the right connection to a growing
market. This revitalization is built for longevity. We have never
been poised and positioned better for the right alliances and
acquisitions. The organization today has taken the position of
being the central point partner and provider of services and
products that are crucial in the fight against diseases.
We have proven to be a pioneer in formulation, production, and
commercialization of proprietary nutritional and medical
supplements designed to improve customers’ health and longevity. We
focus on advanced acute clinical support and alternative medicine
for both short and long term use in any age group. By working with
practitioners, high-end physicians, a collective of nutritional
scientists, and chief nutraceutical formulators, we are able to
produce cutting edge developments within both the nutraceutical and
health and wellness fields. With the company’s proprietary
formulations and methodologies having attracted the attention of
the market from customers to the international wellness community,
we are able to leverage our global expertise and connect commerce
to meet the growing demand for products and services.
Because of our developments in global marketing strategies and
centralization of the manufacturing process, NutraNomics has
created a strong network of global raw producers, distributors, and
technology partners to meet those growing demands. Essentially, our
company has evolved to become a one-stop-shop for nutraceutical
needs. With emphasis on research and development, formulation,
marketing, and manufacturing, our 360 approach to client care is
constructed to confront the needs of our clients head-on while
drastically simplifying the process. This investment has paid off
immediately with increased sales and an operational structure that
allows us to expand our profitability while growing revenues.
We are poised for continued and expansive growth.
Safe Harbor Statement
This press release contains forward-looking statements that can
be identified by terminology such as "believes," "expects,"
"potential," "plans," "suggests," "may," "should," "could,"
"intends," or similar expressions. Many forward-looking statements
involve known and unknown risks, uncertainties and other factors
that may cause actual results to be materially different from any
future results or implied by such statements. These factors
include, but are not limited to, our ability to continue to enhance
our products and systems to address industry changes, our ability
to expand our customer base and retain existing customers, our
ability to effectively compete in our market segment, the lack of
public information on our company, our ability to raise sufficient
capital to fund our business, operations, our ability to continue
as a going concern, and a limited public market for our common
stock, among other risks. Many factors are difficult to predict
accurately and are generally beyond the company's control.
Forward-looking statements speak only as to the date they are made
and we do not undertake to update forward-looking statements to
reflect circumstances or events that occur after the date the
forward-looking statements are made.
Contact:
Jonathan BishopCEO
NutraNomics Inc.
www.NutraNomics.com
Phone:(888) 935-0530
Grafico Azioni Nutranomics (CE) (USOTC:NNRX)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Nutranomics (CE) (USOTC:NNRX)
Storico
Da Gen 2024 a Gen 2025